New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 17, 2014
08:05 EDTKERXKeryx announces marketing approval of ferric citrate in Japan
Keryx announced that its Japanese partner, Japan Tobacco has received manufacturing and marketing approval of ferric citrate from the Japanese Ministry of Health, Labour and Welfare. Under the license agreement with JT and Torii, within 30 days, Keryx will receive a non-refundable payment of $10M for the achievement of the marketing approval milestone. Keryx will also receive double-digit tiered royalties on net sales of Riona in Japan, as well as up to an additional $55M upon the achievement of certain annual net sales milestones.
News For KERX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 21, 2015
19:55 EDTKERXKeryx 9.17M share Secondary priced at $12.00
The deal size was raised to 9.17M shares from 7.2M shares. JPMorgan acted as sole book running manager for the offering.
January 20, 2015
18:30 EDTKERXOn The Fly: After Hours Movers
Subscribe for More Information
16:06 EDTKERXKeryx files to sell $100M in common stock
J.P. Morgan is acting as the sole book-running manager in the offering. Keryx intends to use the net proceeds from the sale of its common stock to fund the ongoing commercialization and development of Auryxia in the US, pre-commercial activities in Europe, to potentially in-license, acquire and develop additional drug candidates, and other general corporate purposes.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use